ArticleAmerican journal of obstetrics and gynecology2021

Predictors of response for elagolix with add-back therapy in women with heavy menstrual bleeding associated with uterine fibroids.

Ayman Al-Hendy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.